Login to Your Account

Novartis buy-in boosts Mereo's $21.3M raise; cash runway until 2018

By Nuala Moran
Staff Writer

Monday, June 6, 2016

LONDON – Less than one year after arriving on the scene with a $119 million series A, Mereo Biopharma Ltd. has raised a further $21.3 million and is joining the Alternative Investment Market in London.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription